Trials and Tribulations of Cell Therapy for Heart Failure, an Update on Ongoing Trials Dec. 2, 2024 — A critical review of cell-based and cell product-based therapies for the treatment of heart ...
The following is a summary of “Safety of Diltiazem for Acute Management of Atrial Fibrillation (AF) in Patients with Heart Failure and Reduced Ejection Fraction in the Emergency Department,” published ...
This study is the first to inject repeated doses of stem cells intravenously into patients who have heart failure due to a heart attack or coronary artery disease.